Hikal is currently trading at Rs. 616.00, up by 3.15 points or 0.51% from its previous closing of Rs. 612.85 on the BSE.
The scrip opened at Rs. 605.90 and has touched a high and low of Rs. 650.00 and Rs. 605.90 respectively. So far 6087 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 656.00 on 21-Jul-2014 and a 52 week low of Rs. 384.00 on 29-Jul-2013.
Last one week high and low of the scrip stood at Rs. 650.00 and Rs. 606.20 respectively. The current market cap of the company is Rs. 1020.60 crore.
The promoters holding in the company stood at 68.83% while Institutions and Non-Institutions held 13.97% and 17.20% respectively.
Hikal has successfully completed an inspection by European Directorate for the Quality of Medicines (EDQM) at its manufacturing facility at Bangalore. The primary focus of the inspection was the adherence to compliance and implementation of a suitable Quality Management System based on the Good Manufacturing Practice as laid down in the EU Rules governing Medicinal products in the European Union.
The inspection concluded that the company operated in accordance with the rules and regulations of the governing authorities based in the European Union and Hikal’s adherence to the highest standards of product quality and global regulatory compliance procedures as part of its fundamental value system. The successful completion of this audit is a positive reflection of company’s people, systems and procedures and commitment to Company's global customer base.
Hikal is a provider of solutions & reliable long-term outsourcing partner to companies in the Pharmaceuticals, Crop Protection, Animal health, and Specialty Chemicals industry. The company has been supplying key active ingredients (AI) and intermediates, manufactured using stringent global quality standards, for its customers in the United States, Europe and Japan.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |